In an exciting development for the medicinal cannabis community, recruitment has now commenced for a world-leading clinical trial evaluating three pharmaceutical-grade medicinal cannabis oils for the treatment of chronic pain originating from musculoskeletal conditions. The study is spearheaded by respected Principal Investigator, Dr Matthew Moore MD FAAFP FACRRM EM Cert, and financially sponsored by Levin Health, an Australian sports science company.
About the Trial
Levin Health is focused on researching, developing, and commercialising medicinal cannabis products for pain treatment, mental health disorders, and sports-related ailments. This double-blind, placebo-controlled, randomised trial aims to examine the effectiveness of Levin Health’s licensed formulas in managing chronic musculoskeletal pain.
Study Objectives
The study seeks to determine if there is an improvement in patient-reported outcome measures over a 12-week period while using a standardised oral formulation of medicinal cannabis (MC) oil. The trial will also monitor any adverse outcomes that might occur during the medication intake.
Study Design
The trial’s design is a prospective, longitudinal observational study involving a defined population. The trial’s ultimate objective is to ascertain if this specific medication necessitates further and more rigorous clinical trial investigation as a potential treatment for chronic musculoskeletal pain.
The Interventions
The study’s unique approach will involve three distinct Levin Health products: Levin Health CBD+, Levin Health Balance, and Levin Health THC+. The choice of prescription for each participant will be at the clinical discretion of the Principal Investigator.
Participants will complete standardized and validated electronic Patient Reported Outcome Measures (PROMs) weekly using their home computers or devices. These measures will be compared to baseline measures taken at the beginning of the study.
Eligibility and How to Join
If you are interested in participating or know someone who might be, you can check your eligibility by completing this Medicinal Cannabis Musculoskeletal Pain Study – Patient Eligibility Questionnaire: here.
Further Information
For more information, feel free to contact Sharlene Mavor at sharlene@mavor.com.au.
This trial is a significant step forward in our understanding of the potential benefits of medicinal cannabis in treating chronic pain, so don’t miss the opportunity to be part of this groundbreaking study.
ANZCTR Listing here.
Registration Number: ACTRN12622000750785
Support Your Chronic Pain Management with the Sunbeam Multipurpose Electric Heating Pad XL
Living with chronic pain can often feel like an unending journey, but relief may be closer than you think. The Sunbeam Multipurpose Electric Heating Pad XL, a highly-rated product, offers versatile healing comfort, targeting multiple areas of your body with its expansive coverage.
The Sunbeam heating pad’s brilliance lies in its innovative Intellisense technology, ensuring consistent temperature and safe use. Its auto-off safety feature, which turns off the device after three hours of use, and five customisable heat settings put you in complete control of your comfort. In just 90 seconds, it heats up, providing prompt relief.
Made for practical and comfortable use, the Sunbeam heating pad is covered with a soft, machine-washable fabric and features a detachable controller for easy cleaning. Customers dealing with chronic pain and insomnia have reported significant benefits. Sandra S, a verified purchaser, praised its “consistent heat” and larger coverage area, while another user, Lauren, finds it invaluable for her lower back pain.
The Sunbeam Multipurpose Electric Heating Pad XL isn’t a cure, but it’s an effective tool in your chronic pain toolkit. Check it out here: Sunbeam Heat Pad XL – remember, each purchase through this link supports our research and keeps you updated on the latest medicinal cannabis news.